First Line Ovarian Cancer Treatment - Cohort Study
Epithelial Ovarian Cancer
Conditions: official terms
Neoplasms, Glandular and Epithelial - Ovarian Neoplasms
Conditions: Keywords
First line treatment, Ovarian cancer, Avastin, fallopian tube or primary peritoneal
Study Type
Observational [Patient Registry]
Study Phase
Study Design
Observational Model: Cohort, Time Perspective: Prospective
Name: Bevacizumab
Type: Drug
Overall Status
The French cooperative group GINECO proposes to implement an observational study to describe a real situation, in daily practice tolerance and methods of administration of bevacizumab (Avastin ®)
Detailed Description
Population: Patients aged 18 years and older with an epithelial ovarian cancer, fallopian tube or primary peritoneal or witch it was decided to initiate a process comprising of Bevacizumab (Avastin ®) in first-line therapy
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Female
Criteria: Inclusion Criteria:

- Patients aged 18 years and over,

- Patients with an epithelial ovarian cancer, fallopian tube or peritoneal who will receive bevacizumab (Avastin ®) in first-line therapy

- Patients should be informed of the study orally and should not have any objection their data to be processed.

Exclusion Criteria:

- Patient participation in a clinical trial

- Patient non-affiliated to a social security scheme.
Centre Paul Papin
Angers, France
Status: Recruiting
Clinique Tivoli
Bordeaux, France
Status: Recruiting
Institut Bergonié
Bordeaux, France
Status: Recruiting
Centre jean Perrin
Clermont Ferrand, France
Status: Recruiting
Centre Hospitalier Intercommunal
Fréjus, France
Status: Recruiting
institut Paoli Calmette
Marseille, France
Status: Recruiting
Clinique Valdegour
Nimes, France
Status: Recruiting
Centre Hospitalier Régional
Orléans, France
Status: Recruiting
Paris, France
Status: Recruiting
Contact: Douglas MICHEAU-BONNIER - +33 1 42 34 83 23 -
Centre Hospitalier Lyon-sud
Pierre-Bénite, France
Status: Recruiting
Contact: Gilles Freyer, MD, PhD - + 33 (0) 478863324
Institut Jean Godinot
Reims, France
Status: Recruiting
Clinique Armoricaine de Radiologie
Saint Brieuc, France
Status: Recruiting
ICO René Gauducheau
St Herblain, France
Status: Recruiting
Hôpital Civil
Strasbourg, France
Status: Recruiting
Start Date
April 2013
Completion Date
January 2018
Record processing date processed this data on July 28, 2015 page